Page: Memantine product-specific bioequivalence guidance-2025/6/30

Page: Posaconazole product-specific bioequivalence guidance-2025/6/30

Document: Infosheet: EMA review of real-world data studies from September 2021 to February 2025-2025/6/30

Document: Real-world evidence framework to support EU regulatory decision-making: 3rd report on the experience gained with regulator-led studies from February 2024 to February 2025-2025/6/30

Page: Reflection paper on lessons learned from the COVID-19 pandemic: Scientific considerations on non-clinical aspects-2025/6/30

Page: ICH E20 adaptive designs for clinical trials - Scientific guideline-2025/6/30

Document: ICH E20 guideline on adaptive designs for clinical trials - Step 2b-2025/6/30

Page: Lurasidone product-specific bioequivalence guidance-2025/6/30

Document: List of centrally authorised products with safety-related changes to the product information-2025/6/30

Page: Apixaban product-specific bioequivalence guidance-2025/6/30